Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
      Google Scholar   
Citation:
Ann. Oncol. vol 18 (6) 1071-9
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
792  
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
CA03927, CA04326, CA07968, CA11789, CA12046, CA12449, CA26806, CA31946, CA32291, CA33601, CA35113, CA41287, CA45389, CA45808, CA47642, CA77440, CA77597, CA77651, CA77658  
Corr. Author:
 
Authors:
                   
Primary Study
CALGB-59804
Secondary Studies:
Phases:
1/2
Keywords:
Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Dacarbazine, Deoxycytidine, Disease-Free Survival, Dose-Response Relationship, Drug, Doxorubicin, Hodgkin Disease, Humans, Middle Aged, Neutropenia, Patient Selection, Polyethylene Glycols, Salvage Therapy, Survival Analysis, Thrombocytopenia, Treatment Outcome, Vinblastine